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Bmal1 regulates inflammatory 
responses in macrophages by 
modulating enhancer RNA 
transcription
Yumiko Oishi1, Shinichiro Hayashi1, Takayuki Isagawa2, Motohiko Oshima3, Atsushi Iwama3, 
Shigeki Shimba4, Hitoshi Okamura5 & Ichiro Manabe6
Bmal1 (encoded by Arntl gene) is a core circadian clock gene that regulates various genes involved 
in circadian rhythm. Although Bmal1 is expressed rhythmically in macrophages, the role of Bmal1 in 
the regulation of their cellular function remains insufficiently understood. Here, we report that Bmal1 
regulates time-dependent inflammatory responses following Toll-like receptor 4 (TLR4) activation 
by modulating enhancer activity. Global transcriptome analysis indicated that deletion of Arntl 
perturbed the time-dependent inflammatory responses elicited by TLR4 activation by Kdo2-lipid A 
(KLA). Although the recruitment of NF-κB p65 was unaffected, the acetylation status of lysine 27 of 
histone 3, which correlates positively with enhancer activity, was globally increased at PU.1-containing 
enhancers in Arntl−/− macrophages as compared to wild-type cells. Expression of Nr1d1 and Nr1d2, 
encoding RevErb transcription factors, which repress enhancer RNA expression, was significantly 
decreased in Arntl−/− macrophages. Moreover, the level of H3K27 acetylation was increased by Arntl 
deletion at RevErb-dependent eRNA-expressing enhancers. These results suggest that Bmal1 controls 
KLA-responsive enhancers, in part by regulating RevErb-directed eRNA transcription. Taken together, 
the results of this study show that the clock transcription factor network containing Bmal1 controls the 
inflammatory responses of macrophages by regulating the epigenetic states of enhancers.
The circadian clock is an endogenous oscillator that drives the diurnal rhythms of physiology and behavior. In 
mammals, the circadian system has a hierarchical architecture, composed of a light responsive central clock 
in the suprachiasmatic nuclei and a peripheral clock present in all the cells of the body. The circadian clock-
work is driven by a molecular feedback loop in which a heterodimer composed of circadian locomotor out-
put cycles kaput (Clock) and brain and muscle Arnt like protein-1 (Bmal1) drives expression of two inhibitors, 
cryptochrome (Cry) and period (Per)1, 2. These feedback loops generate circadian transcription and translation 
rhythms. In an additional regulatory loop, Clock and Bmal1 transactivate the nuclear receptor genes Rora, encod-
ing RORα, and Nr1d1/2, encoding RevErb-α and -β. RORα in turn activates and RevErbs repress transcription 
of Arntl, encoding Bmal1. In this way, these nuclear receptors function as a stabilizing loop3. Together, these 
feedback loops generate a repeated transcriptional/translational oscillator with a 24-hour period.
Recent evidence suggests that clock genes are involved in the regulation of numerous physiological pro-
cess, including metabolism, development and aging. For instance, systemic deletion of Arntl in mice resulted in 
impaired circadian behavior, loss of the rhythmicity of target gene expression, acceleration of aging processes4, 
and metabolic disorders5–7. Immune responses also show day-night difference8. For instance, susceptibility to 
LPS-induced endotoxin shock shows diurnal variability in mice9. Induction of several proinflammatory cytokines 
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was greater when mice were challenged with LPS at ZT12 (start of dark phase) than at ZT0 (start of light phase)10. 
Moreover, perturbation or desynchronization of the clock by modulating light input alters immune function9, 11. 
Because clock genes oscillate in isolated immune cells, including macrophages12, the peripheral cellular clock 
within immune cells are likely to be involved in controlling the daily function of immune cells in addition to the 
central oscillator in the brain.
Macrophages are an essential component of the innate immune system. Acting via various pattern rec-
ognition receptors, such as Toll-like receptors (TLRs), macrophages respond to danger signals, including 
pathogen-associated molecular patterns such as LPS and damage-associated molecular patterns such as HMGB1 
and DNA, which are endogenous molecules associated with cell and tissue injury. For instance, TLR4 senses LPS 
and activates NF-κB, AP-1 and IRF3 transcription factors, triggering transcriptional events that culminate in 
proinflammatory activation of macrophages13. The peripheral clock is present in myeloid lineage cells, including 
macrophages. Myeloid cell-specific deletion of Arntl disrupted the rhythmic cycling of blood Ly6Chi monocytes 
and predisposed mice to the development of pathologies such as acute inflammation induced by L. monocy-
togenes infection and metabolic disorders associated with high-fat diet-induced obesity14. In that study, Bmal1 
was found to directly suppress transcription of the proinflammatory genes Ccl2, Ccl8 and S100a8. Macrophages 
with low Bmal1 levels (e.g., ZT12 or circadian desynchronization) also showed higher expression of several 
proinflammatory cytokines11, 15. Based on these results it was suggested that Bmal1 acts as an anti-inflammatory 
molecule in monocytes/macrophages8. However, Bmal1’s function appears not to be limited to suppression of 
inflammatory activation of monocytes/macrophages. For instance, Bmal1 reportedly controls expression of Tlr9 
in macrophages, and in a TLR9-dependent mouse sepsis model, sepsis was worse in mice that underwent the 
model at ZT19, when Tlr9 expression is normally at its peak16.
While the circadian clock greatly affects immune responses, inflammation appears to affect the clock in 
reverse. Wang et al. showed that LPS induces a phase shift in the Per2 rhythm in synchronized peritoneal mac-
rophages17. LPS also transiently reduces Arntl mRNA levels17, 18. Collectively, these results demonstrate that the 
circadian clock and immune system are tightly linked to one another. However, the impact of the linkage between 
the cellular clock and the regulatory machinery of inflammatory responses and global gene regulation in mac-
rophages is still insufficiently understood. In the present study, we analyzed the effects of Bmal1 on the transcrip-
tome and enhancer landscape in macrophages.
Results
Time-dependent inflammatory responses are disturbed in Arntl−/− macrophages. To elucidate 
the genome-wide function of the clock protein Bmal1 in the machinery regulating the inflammatory responses 
of macrophages, we first examined the effects of Arntl deletion on the transcriptome. Bone marrow-derived mac-
rophages (BMDMs) were prepared from Arntl−/− mice or their wild-type (WT) littermate controls. The cells were 
stimulated with Kdo2 lipid A (KLA), a chemically defined substructure of bacterial lipopolysaccharide (LPS) that 
is specifically recognized by TLR419, after which the transcriptome was analyzed over the course of the inflam-
matory response through RNA-sequencing (RNA-seq). RefSeq genes with normalized counts ≥100 at one or 
more time points in WT macrophages (a total of 9,720 genes) were clustered into 5 groups using the Mfuzz clus-
tering method20, and the temporal changes in gene expression in each cluster were compared between WT and 
Arntl−/− macrophages (Fig. 1). In all clusters, expression of many genes was affected by Arntl deletion, and expres-
sion patterns appeared to be desynchronized, particularly in clusters 1–3. Notably, the expression patterns of the 
KLA-induced genes in clusters 1 and 2 were strikingly disturbed in Arntl−/− macrophages. In WT cells, genes in 
clusters 1 and 2 were upregulated after KLA treatment, and the expression of core genes involved in those clusters 
reached a peak at 6 h. In Arntl−/− cells, by contrast, the clear induction pattern of those genes seen 6 h after KLA 
treatment was lost. Instead, expression of many of those genes reached peaks 24 h after KLA treatment, indicating 
a marked delay in the KLA response. Moreover, whereas expression of genes in cluster 3 sharply dipped after 6 h 
in WT cells, this nadir was absent in Arntl−/− macrophages. Gene ontology analysis indicated that genes related to 
inflammatory responses and cellular metabolism were significantly enriched in clusters 1–3. In particular, the GO 
terms “innate immune response” and “IκB kinase/NF-κB signaling” were enriched in cluster 1 (Fig. 1). Similarly, 
the GO terms “NF-κB signaling pathway” and “innate immune system” were enriched in cluster 2. Cluster 3 was 
also associated with innate immune responses. These findings suggest that the innate immune responses medi-
ated via NF-κB signaling were disturbed in Arntl−/− macrophages, due to the delayed and/or desynchronized 
transcriptome response to TLR4 activation.
Expression of genes belonging to clusters 4 and 5 were also disturbed by Arntl deletion; however, the trends 
in the gene expression of the core members appeared to be less affected by Arntl deletion than in clusters 1–3. 
In addition, clusters 1–3 contained genes regulated by NF-κB signaling. Given these results, we will focus on the 
inflammatory responsive genes under the control of TLR4 signaling in the following analyses.
Inflammatory response-related gene expression is disturbed in Arntl−/− macrophages. The 
results of our RNA-seq clearly indicate that TLR4-responsive transcriptome activation is delayed or desynchro-
nized in Arntl−/− macrophages. Based on these results, and given the role of Bmal1 as a central transcription 
factor within the cellular clock, we hypothesized that Bmal1 contributes to the time-dependent regulation of 
inflammation-related gene expression in macrophages. To test that idea, we first assessed the effect of TLR4 acti-
vation by KLA on the expression of clock genes. Expression of Arnt1 and Per1/2 was transiently downregulated 
4 h after KLA treatment (Supplementary Fig. S1). Cry1/2 was upregulated after KLA treatment; its expression 
showed a peak at 8 h. The effects of TLR4 activation on Arntl expression are consistent with earlier reports17, 18 and 
demonstrate that TLR4 activation by KLA induces time-dependent changes in clock gene expression.
To characterize the effect of Arntl deletion on induction of inflammatory response-related genes, we further 
investigated the genes classified as cluster 1 (1,758 genes). The temporal expression profiles of these genes were 
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Figure 1. Clustering and time-course expression of genes after TLR4 activation. Bone marrow-derived 
macrophages prepared from WT and Arntl−/− mice were treated with KLA for 0, 6, 24 or 48 h, after which 
their transcriptomes were analyzed using RNA-seq. RefSeq genes with normalized counts ≥100 at one or 
more time point in WT macrophages were clustered into 5 groups using the Mfuzz clustering method20. Prior 
to Mfuzz clustering, normalized counts were standardized so that the average counts for each gene was zero 
and the standard deviation was one. The genes with membership scores ≥0.3 were chosen as the members of 
each cluster in the following analyses. Expression levels of each gene (Z-score) are shown as line graphs. The 
color gradient of lines from purple to pink indicates the membership score. Normalized counts of each gene 
in Arntl−/− cells were also standardized and shown as line graphs. GO terms associated with each cluster are 
shown.
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evaluated by comparing the expression levels of individual genes at 0, 6 and 24 h after KLA treatment in WT 
and Arntl−/− macrophages (Fig. 2a and b, Supplementary Fig. S2). While expression of the majority of cluster 
1 genes was higher at 6 h than at baseline (0 h) in WT cells, expression of these genes remained unchanged in 
Arntl−/− cells (Fig. 2a). Many cluster 1 genes in WT cells were slightly inhibited or unchanged at 24 h, as com-
pared to their expression levels at 6 h. In Arntl−/− cells, by contrast, expression levels of the majority of these genes 
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Figure 2. Prolonged inflammatory response in Arntl−/− macrophages. (a,b) Scatter plots depicting the 
relationship between log2 normalized counts of cluster 1 genes in WT and Arntl−/− macrophages treated with 
KLA for 0 or 6 h (a) and 6 or 24 h (b). Gray dots indicate all RefSeq genes with counts ≥100 at one or more time 
points in WT macrophages. Blue and red dots represent the genes belonging to cluster 1 in WT and Arntl−/− 
macrophages, respectively. Lines indicating a 1.5-fold change are shown. (c) Relative mRNA expression of Nos2 
and Il1b in WT and Arntl−/− macrophages treated with KLA for the indicated times. n = 3 for each group at 
each time point. (d) Levels of IL-1β protein in the culture media of WT and Arntl−/− BMDMs stimulated with 
KLA plus ATP. n = 10 for each group. (e,f) Relative mRNA expression of Csf1r (e) and Hif1a (f) in WT and 
Arntl−/− macrophages treated with KLA for the indicated times. n = 3 for each group at each time point. For 
qPCR in (c,e and f) expression levels were first normalized to those of 18 s rRNA and then further normalized to 
the levels in WT cells at 0 h. *p < 0.05, **p < 0.01 between WT and Arntl−/− cells at the same time point.
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gene expression levels in WT and Arntl−/− at each time point. Expression of the majority of cluster 1 genes 
was higher in Arntl−/− cells at 0 h, lower at 6 h, and higher at 24 h than in WT cells (Supplementary Fig. S2). 
Collectively, expression of cluster 1 genes in Arntl−/− cells showed a trend toward basal activation and delayed 
and/or enhanced expression later, at 24 h.
Quantitative PCR (qPCR) analysis independently confirmed that expression of proinflammatory genes 
belonging to cluster 1, including Nos2 and Il1b, remained significantly elevated 24, 48 and 72 h after TLR4 activa-
tion in Arntl−/− cells as compared to WT cells (Fig. 2c). Thus activation of these genes in Arntl−/− macrophages 
was both enhanced and prolonged. Consistent with the enhanced Il1b mRNA expression, levels of secreted IL-1β 
protein were significantly increased in the Arntl−/− BMDMs as compared to WT cells (Fig. 2d).
As in cluster 1, the upregulation of core members of cluster 2 genes seen at 6 h in WT cells was absent in 
Arntl−/− cells (Fig. 1). For instance, our qPCR showed that in Arntl−/− cells, expression of Csf1r remained low 6 h 
after LPS treatment but was higher after 24 h, suggesting induction of Csf1r was delayed and sustained in Arntl−/− 
cells (Fig. 2d). qPCR also showed that expression of Hif1a, belonging to the cluster 3, was enhanced at most time 
points in Arntl−/− cells. Collectively, these findings indicate that TLR4-mediated expression of a number of proin-
flammatory genes is enhanced and/or sustained in Arntl−/− macrophages.
Bmal1 binds to PU.1-associated regulatory regions. We next analyzed the mechanism by which 
Bmal1 affects the temporal proinflammatory gene response to TLR4 activation. To that end, ChIP-seq of 
Bmal1 was performed in mouse primary macrophages (thioglycolate-elicited peritoneal macrophages). As 
expected, Bmal1 binding to clock gene loci was observed (data not shown). Interestingly, Bmal1 binding was 
also observed in the regulatory regions of TLR4-inducible genes exemplified by Hif1a (cluster 1) and Csf1r 
(cluster 2) (Fig. 3a). In addition, de novo motif analysis identified a motif for basic helix-loop-helix (bHLH) 
transcription factors, including NPAS2, as the most highly enriched sequence followed by motifs for PU.1, 
a macrophage lineage-determining transcription factor, and AP-1 and C/EBP, two transcription factors 
known to be involved in macrophage activation (Fig. 3b). This suggests Bmal1 associates with enhancers 
bound by transcription factors important for the regulation of macrophage function, including PU.1, AP-1 
and C/EBP.
Previous studies demonstrated that PU.1 is necessary for establishing macrophage-specific cistromes for 
signal-responsive transcription factors, including NF-κB21, 22. We found that deletion of Arntl affected expres-
sion of NF-κB-regulated genes (Fig. 1). Based on those observations, we hypothesized that Bmal1 may co-bind 
to its cognitive sites along with NF-κB and/or PU.1. Indeed, approximately half of the 2,026 Bmal1 peaks were 
co-occupied by PU.1 (1,040 sites; 51%). Moreover, 729 sites (36%) were co-occupied by p65, and 611 sites 
(30%) were co-occupied by both p65 and PU.1 (Fig. 3c). These results suggest that Bmal1 may directly affect 
PU.1-containing enhancers after TLR4 activation. Given that PU.1 acts as a macrophage lineage-determining 
transcription factor that is essential for establishment of macrophage-specific enhancers13, 23, the extensive 
co-binding of Bmal1 with PU.1 suggests Bmal1 is involved in macrophage-specific regulatory programs, such as 
inflammatory responses. Consistent with that idea, only a small fraction (5.5%) of macrophage Bmal1 binding 
peaks were shared between macrophages and the liver24 (Fig. 3d), suggesting the targets regulated by Bmal1 dif-
fer between macrophages and the liver. In macrophages, moreover, the target genes containing Bmal1 binding 
sites predicted by GREAT (genomic regions enrichment of annotations tool)25 were significantly associated with 
different GO terms than liver, with the exception of circadian rhythm-related terms (Supplementary Fig. S3). It 
thus appears that, aside circadian regulation, Bmal1 has different regulatory functions in macrophages than in 
the liver.
Loss of Arntl alters the enhancer landscape. Given the role of NF-κB as a primary driver of 
TLR4-mediated inflammatory transcriptional activation, we hypothesized that perturbed NF-κB binding, namely 
delayed and prolonged association of NF-κB in response to TLR4 activation, is the mechanism responsible for 
the altered temporal proinflammatory gene expression in Arntl−/− macrophages. To test that idea, we performed 
ChIP-seq of the p65 component of NF-κB in WT and Arntl−/− macrophages, after which the temporal pattern of 
p65 binding was analyzed in WT and Arntl−/− macrophages. Consistent with previous studies21, 26, the average 
p65 binding was increased at PU.1-binding sites 4 h and 8 h after KLA treatment in WT macrophages, and was 
then lower at 12 h and later (Fig. 4, left column). Unexpectedly, however, Arntl deletion did not affect average p65 
association with PU.1 loci (Fig. 4, left column).
The unexpected finding that p65 recruitment was unaffected by loss of Arntl prompted us to analyze the 
enhancer landscape. To assess global enhancer activity, we performed ChIP-seq of lysine 27-acetylated histone H3 
(H3K27ac), which is positively associated with transcriptional activity27, 28. Interestingly, average H3K27 acetyla-
tion levels at all PU.1 binding sites were higher in Arntl−/− than WT macrophages at baseline and throughout the 
course of the response after KLA stimulation (Fig. 4, right column).
To further assess epigenetic changes, we first analyzed the density of H3K27ac in PU.1/Bmal1 co-binding 
regions to analyze possible direct effects of the loss of Bmal1. ChIP-seq tags for Bmal1, PU.1 and H3K27ac around 
the top 500 Bmal1 binding sites at baseline, were grouped into 5 clusters using the K-means clustering algorism. 
A heat map of Bmal1, PU.1 and H3K27ac reads around PU.1 peaks shows that while H3K27ac levels in cluster 
A were unchanged or decreased in Arntl−/− cells, H3K27ac levels in clusters B, C and D were clearly higher in 
Arntl−/− cells than WT cells under basal conditions (Fig. 5a). In agreement with the results of the top 500 Bmal1 
sites, average H3K27ac levels around all Bmal1-PU.1 co-binding sites were increased in Arntl−/− cells as com-
pared to WT cells (Supplementary Fig. S4). The changes are exemplified by the KLA-inducible Arntl target genes 
Hif1a and Csf1r (Fig. 5b). These results indicate that loss of Bmal1 leads to increased H3K27 acetylation at most 
enhancers to which Bmal1 and PU.1 bind.
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Although Arntl deletion globally affected the H3K27ac states at PU.1 sites (Fig. 4 right column), only a minor 
fraction of PU.1 sites were cobound by Bmal1 (Fig. 3c). Therefore, the differential deposition of H3K27 acetyl-
ation at PU.1-contining enhancers cannot be fully explained as a primary effect of the loss of Bmal1 binding. 
Accordingly, we further characterized the mechanism underlying the changes in H3K27 acetylation. TLR4 acti-
vation can both activate and repress PU.1-bound enhancer activity concomitantly with changes in H3K27 acetyl-
ation26. To dissect the epigenetic effect of the loss of Bmal1 in line with our focus on KLA-activated genes in the 
present study, we focused on the PU.1 enhancers at which H3K27ac was increased by KLA. Furthermore, to focus 
on early KLA-activated enhancers, we analyzed the PU.1 sites at which H3K27ac tags were increased ≥2-fold 
as compared to the steady state 4 h after KLA stimulation (5,572 peaks). In WT cells, H3K27ac levels at these 
KLA-activated enhancers were increased at 4 h and then gradually declined (Fig. 6a). By contrast, the average 
deposition of H3K27ac was already high at baseline in Arntl−/− macrophages. And while H3K27ac levels were 
comparable between the two genotypes 4 h after KLA, the elevation in H3K27ac persisted beyond 4 h in Arntl−/− 
cells. These altered H3K27ac states are exemplified by the Irf1 locus (Fig. 6b). Moreover, the persistent activation 
Figure 3. Bmal1 co-localizes with PU.1 and NF-κB. (a) UCSC genome browser image illustrating normalized 
tag counts for ChIP-seqs of Bmal1, PU.1, and p65 around the Hif1a and Csf1r loci. (b) de novo motifs identified 
in regions bound by Bmal1 in macrophages. (c) Venn diagram showing the overlap between the PU.1, p65 
and Bmal1 peaks identified using ChIP-seq. Note more than half of the Bmal1 peaks (1,158 of 2,026 peaks) 
were also bound by PU.1 and/or NF-κB p65. (d) Venn diagram showing the overlap between Bmal1 peaks in 
macrophages and liver.
www.nature.com/scientificreports/
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of KLA-responsive enhancers appears to be in agreement with the delayed and prolonged mRNA response to 
KLA treatment for many genes in clusters 1–3 (Fig. 1). Collectively then, these findings suggest the loss of Arntl 
induces an increase in baseline enhancer activity at inflammatory genes, reduces the responsiveness to TLR4 
activation, and prolongs inflammatory responses.
Reduced NR1D1 and NR1D2 (RevErbα/β) activity modifies the enhancer activity in Arntl−/− 
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Figure 4. Average recruitment of NF-κB p65 to all PU.1 binding sites are unaffected by Arntl deletion. NF-κB 
p65 and H3K27ac read density in the vicinity of PU.1-dinging sites in WT and Arntl−/− macrophages treated 
with KLA for indicated times.
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PU.1 sites, we hypothesized that clock-controlled transcription factors are involved. Of particular interest were 
RevErb-α and RevErb-β, encoded by Nr1d1 and Nr1d2, respectively, because these nuclear receptors have been 
shown to regulate expression of genes involved in the control of metabolism and inflammatory responses in mac-
rophages10, 29. In addition, Nr1d1 and Nr1d2 are known targets of Bmal130. Consistent with their involvement, our 
ChIP-seq revealed several Bmal1 binding peaks in the regulatory regions of Nr1d1 and Nr1d2 loci (Fig. 7a), and 
levels of Nr1d1 and Nr1d2 expression were markedly reduced in Arntl−/− macrophages throughout the course 
after KLA stimulation (Fig. 7b).
RevErbs reportedly repress enhancer activity by inhibiting eRNA transcription29. To test whether dysreg-
ulation of eRNA transcription modulates enhancer activity in Arntl−/− cells, we took advantage of previously 
reported global run-on sequencing data (GRO-seq) from Nr1d1/Nr1d2 double knockout (DKO) macrophages29. 
To identify eRNA-expressing enhancers, we first identified regions with significant nascent RNA signals deter-
mined with GRO-seq in WT or DKO cells. After signals detected at gene bodies were excluded, the nascent 
RNA signals with read counts increased ≥1.5-fold in Nr1d1/Nr1d2 DKO cells as compared to WT cells were 
identified. The resultant 575 regions were likely to include the regions in which eRNA expression was upreg-
ulated by DKO. Further, we identified 330 regions with PU.1-binding among the eRNA-expressing enhancers. 
Interestingly, the acetylation status of H3K27 around those eRNA-expressing, PU.1-binding enhancers was mark-
edly higher in Arntl−/− than WT macrophages (Fig. 8a), suggesting the reduced RevErb-mediated suppression 
of eRNA de-repressed the enhancers. Our qPCR results confirmed that the eRNA expression located at −5 kb 
in Mmp9 and +28 kb in Cx3cr1, both of which are targets of RevErb-mediated repression29, was significantly 
Figure 5. Loss of Bmal1 enhances H3K27 acetylation at Bmal1 binding sites. (a) Heatmap for Bmal1, PU.1 and 
p65 binding and H3K27 acetylation within 2 kb around the center of the top 500 Bmal1-PU1 co-binding sites in 
untreated cells. ChIP-seq tags for Bmal1, PU.1 and H3K27ac at baseline, were grouped into 5 clusters using the 
K-means clustering algorism. Corresponding p65 ChIP-seq tag densities in cells at baseline (0 h) and 4 h after 
KLA treatment are also shown. (b) Genome browser snapshots showing Bmal1 and H3K27ac ChIP-seq and 
RNA-seq signals at Hif1a and Csf1 loci.
www.nature.com/scientificreports/
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increased in Arntl−/− macrophages (Fig. 8b). And H3K27ac was also increased at the PU.1-containing enhancers 
(Fig. 8c). Collectively, these results suggest that epigenetic dysregulation of the response to inflammatory TLR4 
activation in Arntl−/− cells is at least partly mediated by dysregulation of eRNA transcription due to impaired 
RevErb function.
Discussion
In the present study, we obtained evidence that the circadian transcription factor Bmal1 plays an essential role 
in the global control of inflammatory gene regulation in macrophages, thereby demonstrating that Bmal1 is an 
important regulator of inflammatory responses. Consistent with our findings, previous studies showed enhanced 
production of the proinflammatory cytokines TNF-α and IL-6 in Anrtl−/− macrophages18; in ZT12 macrophages, 
in which the Arntl levels are the lowest15; and in macrophages from a chronic jet lag model, in which Arntl expres-
sion was repressed11. Of particular note is that Arntl deletion enhanced and prolonged responses of inflammatory 
genes to TLR4 activation (Figs 1 and 2). As shown by the gene expression trends in clusters 1 and 2 (Fig. 1), many 
inflammatory genes are transiently induced early (6 h) but suppressed at later times (24 h) in WT macrophages. 
This suppression at 24 h was impaired by Arntl deletion (Fig. 1). Importantly, previous studies have shown that 
both the early induction and late repression of inflammatory response-related genes are actively controlled by 
extensive networks of signaling molecules and transcriptional and metabolic machinery26, 31. Notably, expression 
of Arntl1 was transiently decreased at 4 h and recovered at later times (Supplementary Fig. S1). While it has been 
proposed that Bmal1 acts as a gatekeeper for inflammatory responses8, our findings suggest Bmal1 has a wider role 
in the time-dependent transcriptional regulation occurring in response to inflammatory stimuli in macrophages, 
such as late inflammatory gene repression. The global effects of Bmal1 on H3K27 acetylation at PU.1-binding 
enhancers (Fig. 4) also support that idea. The observation that LPS induces transient Arntl suppression and a 
Figure 6. H3K27 acetylation at PU.1-bound, KLA-activated enhancers is augmented in Arntl−/− macrophages. 
(a) Density of H3K27ac reads at the PU.1-bound enhancers activated by KLA treatment at 4 h. (b) UCSC 
genome browser image illustrating ChIP-seq signals for H3K27ac at the Irf1 locus in WT and Arntl−/− 
macrophages treated with KLA for the indicated times.
www.nature.com/scientificreports/
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phase shift in the Per2 rhythm17, 18 in synchronized macrophages is also consistent with the notion that the cellu-
lar clock is integral to the time-dependent regulation of gene expression after TLR4 activation.
Our ChIP-seq results show that at nearly half its binding sites, Bmal1 colocalizes with the macrophage 
lineage-determining transcription factor PU.1 (Fig. 3c). This is analogous to the co-binding of Bmal1 with PDX1 
at enhancers in pancreatic beta cells24 and suggests that the targets of Bmal1 are cell type-specific. Consistent 
with that, most Bmal1 binding sites in beta cells are distinct from those in the liver24, 32. We similarly found that 
macrophages and the liver have only a small fraction of Bmal1 binding sites in common (Fig. 3d). Moreover, 
the functions of the target genes appear to differ between macrophages and the liver (Supplementary Fig. S3). 
Of particular interest is that ~36% of Bmal1 binding sites are also bound by NF-κB, which is the primary driver 
of the innate immune response (Fig. 3c). This suggests integration of Bmal1 into the immune control circuitry 
in macrophages. Previous studies identified multiple mechanisms interacting between Bmal1 and NF-κB via 
interference with CLOCK33, interaction with PRC214, and induction of Rev-Erbα and RORα10. These findings 
all suggest Bmal1 is involved in the transcriptional regulatory mechanism governed by NF-κB. It was therefore 
surprising that Arntl deletion had no impact on the average binding of p65 to PU.1 throughout the inflammatory 
response after TLR4 activation. Despite the unchanged p65 binding, H3K27 acetylation at PU.1-binding enhanc-
ers was altered by Arntl deletion (Fig. 3), indicating global epigenetic modulation.
We observed that in Arntl−/− cells, H3K27 acetylation in the region around enhancers activated by TLR4 is 
increased at baseline and shows a blunted response at 4 h as well as prolonged activation (Fig. 6). These obser-
vations are in agreement with the changes in KLA-inducible gene expression patterns (Fig. 1). As with all PU.1 
binding sites, average p65 binding at these KLA-activating enhancers was unaffected by Arntl deletion (data not 
shown), suggesting involvement of epigenetic mechanisms independent of p65 binding. A direct effect of the 
loss of Bmal1 binding could account for the epigenetic changes at direct Bmal1 target genes such as Hif1a and 
Csf1r (Fig. 5). But clearly the loss of Bmal1 had much wider effects on enhancers, even those without detectable 
Bmal1 binding. In addition, while the loss of Bmal1 enhanced H3K27 acetylation at many PU.1 enhancers, it also 
reduced H3K27 acetylation at a minor fraction of target enhancers, exemplified by those at Nr1d1 (Fig. 7). Bmal1 
thus appears to exert both activating and repressing effects at its cognitive regulatory regions. It will be important 
to elucidate how this dual function of Bmal1 is regulated.
Bmal1 also appears to widely exert indirect effects on PU.1 enhancers (Fig. 4). One of the indirect mecha-
nisms identified in the present study is RevErb-mediated eRNA regulation. RevErbs function as transcriptional 
repressors by recruiting the NCoR-HDAC3 corepressor complex to the regulatory regions of target genes34–36, 
and by repressing eRNA transcription, which modulates enhancer function29. RevErb expression was suppressed 
in Arntl−/− macrophages (Fig. 7), which is consistent with the current cellular clock model in that RevErbs are 
directly regulated by Bmal137. In Arntl−/− macrophages, eRNA expression in a subset of RevErb target genes, 
including Mmp9 and Cx3cr1, were de-repressed (Fig. 8). More importantly, our results indicate that the loss of 
Bmal1 increases H3K27 acetylation at enhancers where eRNA transcription is repressed in a RevErb-dependent 
manner29. This suggests Bmal1 regulates enhancer activity in part through RevErb-dependent eRNA repression. 
Figure 7. Nr1d1 and Nr1d2 expression is suppressed in Arntl−/− macrophages. (a) Genome browser snapshots 
of Bmal1 and H3K27ac ChIP-seq and RNA-seq results at Nr1d1 and Nr1d2 loci. (b) Relative expression of 
Nr1d1 and Nr1d2 mRNA in WT and Arntl−/− macrophages treated with KLA for indicated times. n = 3 for each 
group at each time point. *p < 0.05, **p < 0.01. between WT and Arntl−/− at the same time point.
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In the present study, we were able to identify a small number of eRNA-expressing enhancers to which PU.1 
bound. Because levels of eRNA expression are generally lower than levels of mRNA expression, our identification 
of eRNA-expressing regions may not be sufficiently sensitive to identify eRNA-expressing enhancers. It is there-
fore possible that eRNA-mediated changes in enhancer activity contribute much more broadly to the epigenetic 
effects of the loss of Bmal1 than we were able to detect.
Our results suggest Bmal1 controls the timing of gene expression in response to inflammatory activation by 
regulating the epigenetic status of enhancers, in part through regulation of RevErbs and eRNA transcription 
in macrophages. These findings provide insight into the time-dependent control of macrophage inflammatory 
responses. Intricate and coordinated mechanisms affecting transcription, the epigenome and various signaling 
and metabolic pathways control the initial proinflammatory response and the later dampening of proinflam-
matory function and activation of pro-resolution function in macrophages26, 38. The machinery of the cellular 
clock, including Bmal1 and RevErbs, appears to be integral to this time-dependent regulation of macrophage 
function, which is essential for proper activation and resolution of inflammation. Imbalance in the regulation of 
inflammatory activation and resolution can lead to chronic inflammation, which is a pivotal contributor to the 
development of chronic non-communicable diseases (NCDs) such as cardiovascular and metabolic diseases26. 
Figure 8. RevErb-dependent eRNA transcription was de-repressed in Arntl−/− macrophages. (a) Average 
H3K27ac read density around PU.1 binding sites adjacent to the RevErb-regulated eRNA-expressing enhancers 
in WT and Arntl−/− macrophages at steady state. (b) qPCR analysis of eRNAs transcribed at the Mmp9 and 
Cxcr1 enhancers. eRNA expression was compared between WT and Arntl−/− macrophages treated with KLA for 
indicated times. n = 3 for each group at each time point. *p < 0.05 between WT and Arntl−/− at the same time 
point. (c) Genome browser snapshots of GRO-seq signals in WT and Nr1d1/Nr1d2 double knockout cells, and 
ChIP-seq signals for PU.1 and H3K27ac in WT and Arntl−/− cells at steady state.
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In that regard, it is noteworthy that deficiencies in clock genes result in cardiovascular and metabolic disease 
phenotypes in mice39, 40. Given that shift work is known to increase the risk for cardiovascular and metabolic 
diseases and associates with increased inflammatory markers41, 42, it will be important to test whether disturbance 
of clock-dependent regulation of inflammatory time underlies chronic inflammation in NCDs. In particular, 
our results demonstrate that Bmal1 is important not only as a gatekeeper for inflammatory activation in mac-
rophages8, but also for the later damping of inflammatory gene expression. Chronic inflammation in NCDs is 
characterized by failed resolution of inflammation43. Future studies will need to address whether Bmal1 dys-
function is involved in promoting chronic inflammation via its multiple regulatory functions that contribute to 
inflammatory activation and resolution.
Experimental Procedure. Reagents. Kdo2-lipid A was purchased from Avanti Polar Lipids and processed 
as described (http://www.lipidmaps.org/protocols/).
Animals. Arntl−/− mice were generated on a C57BL/6 background as described previously39. Mouse 
thioglycollate-elicited macrophages and bone marrow-derived macrophages were isolated from male 6- to 
9-week-old C57BL/6J (Charles River laboratories) and Arntl−/− mice. All animal experiments were approved by 
the Experimental Animal Care and Use Committee of Tokyo Medical and Dental University and strictly adhered 
to the guidelines for animal experiments of the institute.
Cell Culture. We used BMDMs for all experiments except ChIP-seq for Bmal1. For culture of BMDMs, bone 
marrow was collected from mice by perfusing the medullary cavities of femurs, tibias and iliac bones, after which 
the bone marrow cells were cultured for 6 days in RPMI-1640 medium containing 10% FCS and 20 μg/ml M-CSF 
(R&D). Peritoneal macrophages were harvested by lavage 3 days after intraperitoneal injection of 3 ml of 3% thio-
glycollate medium (http://www.lipidmaps.org/protocols/). The cells were then cultured overnight and adherence 
selected.
RNA and qPCR analysis. Total RNA was isolated from cells, purified using RNeasy columns and treated 
with RNase-free DNase according to the manufacturer’s instructions (Qiagen). For quantitative PCR (qPCR) 
analysis, 1 nM of cDNA or ChIP DNA was used for real-time PCR with gene- or locus-specific primers. qPCR was 
performed on an Applied Biosystems StepOne Plus system using SYBR GreenER master mix (Invitrogen) and the 
following protocol: incubation for 10 min at 50 °C and 10 min at 95 °C followed by 40 cycles of 15 s at 95 °C and 
30 s at 60 °C. Primer sequences for RT-qPCR analysis are listed in Supplementary Table S1.
IL-1β ELISA. BMDMs were stimulated with KLA (100 ng/ml) for 4 h, followed by ATP (5 mM/ml) treatment 
for 16 h. Levels of IL-1β in culture media were quantified using a mouse IL-1β ELISA kit (R&D, #MLB00C) 
according to the manufacturer’s instructions.
Chromatin immunoprecipitation (ChIP). For ChIP assays, anti-NF-κB p65 (sc-372) antibody was pur-
chased from Santa Cruz Biotechnology; anti-Bmal1 (ab93806) and anti-H3K27Ac (ab4729) antibodies were 
from Abcam. For Bmal1 ChIP, 2 × 107 thioglycollate-elicited primary peritoneal macrophages were used. For 
NF-κB p65 and H3K27ac ChIP, 2 × 107 bone marrow-derived macrophage were used. After crosslinking in 1% 
formaldehyde, cells were resuspended in buffer containing 10 mM HEPES/KOH (pH 7.9), 85 mM KCl, 1 mM 
EDTA, 0.5% IGEPAL CA-630 and protease inhibitors and incubated for 5 min. The cells were then spun down and 
resuspended in 500 μl of lysis buffer (50 mM Tris/HCl [pH 7.4], 1% SDS, 0.5% Empigen BB, 10 mM EDTA) with 
protease inhibitors, and the chromatin samples were sheared by sonication. The lysates were diluted with 750 μl 
of dilution buffer (20 mM Tris/HCl, 100 mM NaCl, 0.5% Triton X-100, 2 mM EDTA) and 1% was used as input 
DNA. With the remaining samples, immunoprecipitation was carried out overnight using Dynabeads protein G 
coated with specific antibody. The beads were then washed twice with wash buffer I (20 mM Tris/HCl, 150 mM 
NaCl, 0.1% SDS, 1% Triton X-100, 2 mM EDTA), twice with wash buffer II (10 mM Tris/HCl, 250 mM LiCl, 1% 
IGEPAL CA-630, 0.7% Na-deoxycholate, 1 mM EDTA), once with TE plus 0.2% triton X-100, and once with TE 
plus 50 mM NaCl. The beads were then eluted with elution buffer (TE, 2% SDS), after which the DNA crosslinking 
was reversed, and the DNA was purified using a PCR purification kit (Qiagen) according to the manufacturer’s 
instructions.
Sequencing library preparation. ChIP-seq libraries were prepared using a NEBNext Ultra DNA library 
prep kit for Illumina according to the manufacturer’s instructions. RNA-seq libraries were prepared using a 
NEBNext Ultra RNA library prep kit for Illumina according to the manufacturer’s instructions. Libraries were 
PCR-amplified for 12–15 cycles, and sequenced on a GAIIx, HiSeq. 1500 or HiSeq. 2500 (Illumina).
High-throughput sequencing and data analysis. For macrophage Bmal1, p65 and PU.1 ChIP-seq, 
reads were mapped to the mm9 mouse genome using STAR (Dobin et al., 2013). For liver, Bmal1 reads were 
mapped to the mm9 using bowtie44. Peak calling and annotation were performed using HOMER21. Peaks 
that overlapped with blacklisted regions45 and simple repeat regions were removed. For ChIP-seq analyses, 
Homer-identified peaks whose scores were ≥20 were selected as high-confidence peaks, except liver Bmal1 peaks, 
which were used irrespective of scores in downstream analyses. For macrophage Bmal1 ChIP-seq, Bmal1 peaks 
were pooled from 3 experimental conditions (cells treated with KLA for 0, 4 and 24 h). The data used for liver 
Bmal1 ChIP-seq analysis was from ZT8 cells, as that time point had the largest the number of identified peaks in 
a previous report32. For GRO-seq analyses, de novo transcripts were identified using Homer’s findPeaks program 
with the -groseq option. De novo transcripts that overlapped with blacklisted regions and simple repeat regions 
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were removed. Gene ontology analyses were performed using Metascape software (http://metascape.org/)46. 
Motif analyses were performed using HOMER. PU.1 Publically available ChIP-seq, RevErb ChIP-seq and 
GRO-seq results were downloaded from GEO (GSE62826, GSE45914, and GSE39860). All RNA-seq and 
ChIP-seq data are available in the GEO under the accession number GSE95712.
Statistical Analysis. Differences among more than two groups were analyzed using one-way ANOVA fol-
lowed by Tukey-Kramer post-hoc tests. Values of p < 0.05 were considered statistically significant, except where 
otherwise noted. All data are shown as means ± SEM.
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